Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases

Blood

Volumn 92, Issue 3, 1998, Pages 946-951

  Gu, B ^a   Bendall, L J ^a   Wiley, J S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD11B ANTIGEN; CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN E; L SELECTIN; METALLOPROTEINASE;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032147124     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.946.415a24_946_951     Document Type: Article

References (39)

1. Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A: Expression, structure, and function of the CD23 antigen. Adv Immunol 49:149, 1991
2. Katira A, Knox KA, Finney M, Michell RH, Wakelam M, Gordon J: Inhibition by glucocorticoid and staurosporine of IL-4-dependent CD23 production in B lymphocytes is reversed on engaging CD40. Clin Explmmunol 92:347, 1993
3. Beavil AJ, Edmeades RL, Gould HJ, Sutton BJ: Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD23) and related C-type lectins. Proc Natl Acad Sci USA 89:753, 1992
4. Sarfati M, Nakajima T, Frost H, Kilcherr E, Delespesse G: Purification and partial biochemical characterization of IgE-binding factors secreted by a human B lymphoblastoid cell line. Immunology 60:539, 1987
5. Sarfati M, Bron D, Lagneaux L, Fonteyn C, Frost H, Delespesse G: Elevation of IgE-binding factors in serum of patients with B-CLL derived chronic lymphocytic leukemia. Blood 71:94, 1988
6. Reinisch W, Willheim M, Hilgarth M, Gasche C, Mader R, Szepfalusi S, Steger G, Berger R, Lechner K, Boltz-Nitulescu G: Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J Clin Oncol 12:2146, 1994
7. Zinzani PL, Baccini C, Zaccaria A, Visani G, Buzzi M, Morelli A, Molinari AL, Salvucci M, Bendandi M, Rubboli D, Gherlinzoni F, Zanchini R, Tura S: Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma. Eur J Haematol 57:335, 1996
8. Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D: Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 88:4259, 1996
9. Lowe J, Brown B, Hardie D, Richardson P, Ling N: Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia. Immunol Lett 20:103, 1989
10. Beguin Y, Lampertz S, De Groote D, Igot D, Malaise M, Fillet G: Soluble CD23 and other receptors (CD4, CDS, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia 7:2019, 1993
11. Preece G, Murphy G, Ager A: Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem 271:11634, 1996
12. Jamieson GP, Snook MB, Thurlow PJ, Wiley JS: Extracellular ATP causes loss of L-selectin from human lymphocytes via occupancy of P2Z purinoceptors. J Cell Physiol 166:637, 1996
13. 7). Science 272:735, 1996
14. Rassendren F, Buell GN, Virginio C, Collo G, North RA, Surprenant A: The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem 272:5482, 1997
15. Wiley JS, Chen JR, Snook MB, Jamieson GP: The P2Z-purinoceptor of human lymphocytes: Actions of nucleotide agonists and irreversible inhibition by oxidized ATP. Brit J Pharmacol 112:946, 1994
16. + uptake: Inhibition of fluxes by suramin. Arch Biochem Biophys 305:54, 1993
17. Gargett CE, Wiley JS: The isoquinoline derivative KN-62: A potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol 120:1483, 1997
18. Bendall LJ, Kortlepel K, Gottlieb DJ: Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta 1 and beta 2 integrin mechanisms. Blood 82:3125, 1993
19. Murgia M, Hanau S, Pizzo P, Rippa M, DiVirgilio F: Oxidized ATP: An irreversible inhibitor of the macrophage purinergic-P2Z receptor. J Biol Chem 268:8199, 1993
20. Prystas EM, Parker CJ, Holguin MH, Bohnsack JF: Aberrant glycosylation of L-selectin on the lymphocytes of chronic lymphocytic leukemia. Leukemia7:1355, 1993
21. Spertini O, Freedman AS, Belvin MP, Penta AC, Griffin JD, Tedder TF: Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells. Leukemia 5:300, 1991
22. MEL-14) induced by activators of protein kinase C. J Immunol 144:3130, 1995
23. Feehan C, Darlak K, Kahn J, Walcheck B, Spatola AF, Kishimoto TK: Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor. J Biol Chem 271:7019, 1996
24. Gargett CE, Cornish JE, Wiley JS: ATP, a partial agonist for the P2Z receptor of human lymphocytes. Br J Pharmacol 122:911, 1997
25. Wiley JS, Dubyak GR: Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood 73:1316, 1989
26. 4- receptor-operated ion channel of human lymphocytes. Inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions. Arch Biochem Biophys 292:411, 1992
27. El-Moatassim C, Dubyak GR: A novel pathway for the activation of phospholipase D by P2Z purinergic receptors in BAC1.2F5 macrophages. J Biol Chem 267:23664, 1992
28. Gargett CE, Cornish EJ, Wiley JS: Phospholipase D activation by P2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx. Biochem J 313:529, 1996
29. Tedder TF, Steeber DA, Chen A, Engel P: The selectins: Vascular adhesion molecules. FASEB J 9:866, 1995
30. Kahn J, Ingraham RH, Shirley F, Migaki GI, Kishimoto T: Membrane proximal cleavage of L-selectin: Identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J Cell Biol 125:461, 1994
31. Chen A, Engel P, Tedder TF: Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J Exp Med 182:519, 1995
32. Bazil V: Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 16:135, 1995
33. Belli SI, Sali Adnan, Coding JW: Divalent cations stabilize the conformation of plasma cell membrane glycoprotein PC-1 (alkaline phosphodiesterase I). Biochem J 304:75, 1994
34. Delespesse G, Hofstetter H, Sarfati M: Low-affinity receptor for IgE (FcεRII, CD23) and its soluble fragments. International Arch Allergy & Applied Immunol 90:41, 1989 (suppl 1)
35. Schleiffenbaum B, Spertini O, Tedder TF: Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 119:229, 1992
36. Sarfati M, Luo H, Delespesse G: IgE synthesis by chronic lymphocytic leukemia cells. J Exp Med 170:1775, 1989
37. Dadmarz R, Cawley JC: Heterogeneity of CLL: High CD23 antigen and alpha IFN receptor expression are features of favourable disease and of cell activation. Br J Haematol 68:279, 1988
38. Walcheck B, Kahn J, Fisher JM, Wang BB, Fisk RS, Payan DG, Feehan C, Betageri R, Darlak K, Spatola AF, Kishimoto TK: Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380:720, 1996
39. Milner P, Bodin P, Loesch A, Bumstock G: Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 170:649, 1990